COVID-19

Showing NaN - NaN of 36

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID-19 Trial in United States (NVX-CoV2373 (5µg), NVX-CoV2601 (5µg), NVX-CoV2601(5µg))

Not yet recruiting
  • COVID-19
  • NVX-CoV2373 (5μg)
  • +6 more
  • Birmingham, Alabama
  • +47 more
Jul 2, 2023

COVID-19 Trial in Canada, United Kingdom, United States (mRNA-1283.222, mRNA-1273.222)

Recruiting
  • COVID-19
  • mRNA-1283.222
  • mRNA-1273.222
  • Birmingham, Alabama
  • +209 more
Apr 13, 2023

COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)

Completed
  • COVID-19
  • BRII-196
  • +3 more
  • Tucson, Arizona
  • +106 more
Mar 24, 2023

COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • AZD7442
  • +2 more
  • Tucson, Arizona
  • +123 more
Mar 24, 2023

COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)

Completed
  • COVID-19
  • VIR-7831
  • +2 more
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Worldwide (MP0420, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Denmark, United States (PF-07304814, Placebo, Remdesivir)

Suspended
  • COVID-19
  • Chula Vista, California
  • +39 more
Mar 22, 2023

COVID-19 Trial in Worldwide (ensovibep, Placebo)

Terminated
  • COVID-19
  • Jasper, Alabama
  • +47 more
Dec 21, 2022

COVID-19 Trial in United States (nirmatrelvir, ritonavir)

Recruiting
  • COVID-19
  • Birmingham, Alabama
  • +22 more
Jan 11, 2023

COVID-19, Cardiovascular Diseases, Cardiovascular Risk Factor Trial in Brazil, Mexico, United States (Cannabidiol,

Terminated
  • COVID-19
  • +2 more
  • Cannabidiol, pharmaceutically produced with < 5 ppm THC
  • Placebo
  • Phoenix, Arizona
  • +19 more
Dec 12, 2022

COVID-19 Trial in Worldwide (ADG20, Placebo)

Terminated
  • COVID-19
  • Birmingham, Alabama
  • +94 more
Nov 22, 2022

COVID-19 Trial in United Kingdom, United States (AZD7442, Placebo)

Completed
  • COVID-19
  • Guntersville, Alabama
  • +56 more
Oct 24, 2022

COVID-19 Trial in Puerto Rico, United States (Convalescent Plasma, Masked Saline Placebo)

Terminated
  • COVID-19
  • Convalescent Plasma
  • Masked Saline Placebo
  • Birmingham, Alabama
  • +23 more
Sep 9, 2022

SARS-CoV Infection, COVID-19, Allergic Reaction Trial in United States (Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19

Completed
  • SARS-CoV Infection
  • +3 more
  • Moderna COVID-19 Vaccine
  • +2 more
  • Tucson, Arizona
  • +28 more
Sep 19, 2022

COVID-19 Trial in Worldwide (Remdesivir)

Recruiting
  • COVID-19
  • Birmingham, Alabama
  • +36 more
Aug 18, 2022

COVID-19 Trial in United States (Biological/Vaccine: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period), SARS-CoV-2

Recruiting
  • COVID-19
  • Biological/Vaccine: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
  • +3 more
  • Little Rock, Arkansas
  • +24 more
Aug 2, 2022

COVID-19 Trial in United States (Nirmatrelvir, Ritonavir, Placebo for nirmatrelvir)

Not yet recruiting
  • COVID-19
  • Miami, Florida
  • +2 more
Jul 21, 2022

COVID-19 Trial in Worldwide (PF-07321332, Ritonavir, Placebo)

Active, not recruiting
  • COVID-19
  • Pelham, Alabama
  • +336 more
Jul 21, 2022

COVID-19 Trial in Worldwide (Remdesivir, RDV Placebo, Standard of Care)

Terminated
  • COVID-19
  • Birmingham, Alabama
  • +62 more
Jun 1, 2022

Chronic Pain, Chronic Pain Syndrome, Chronic Pain Due to Injury Trial in United States (Cannabis, Medical, RYAH-Medtech Inhaler)

Recruiting
  • Chronic Pain
  • +32 more
  • Cannabis, Medical
  • RYAH-Medtech Inhaler
  • Boca Raton, Florida
  • +16 more
May 29, 2022

COVID-19 Trial in United States (Niclosamide, Placebo)

Recruiting
  • COVID-19
  • Sheffield, Alabama
  • +8 more
Apr 22, 2022

COVID-19 Trial in Worldwide (Losmapimod oral tablet, Placebo oral tablet)

Terminated
  • COVID-19
  • Losmapimod oral tablet
  • Placebo oral tablet
  • Irvine, California
  • +15 more
Mar 30, 2022